Pharmaceuticals, Biotechnology and Life Sciences
WARMINSTER, Pa., May 26, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive…
Design and rationale of the phase 1/2a open label, multicenter study of the AFM24 monotherapy in patients with advanced EGFR-expressing…
Company announcement – No. 23 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022…
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing,…
Company announcement – No. 24 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and…
The Board learned of the arrest of Dr. Serhat Gumrukçu after the Press Release by the Department of Justice on…
Quorum of 25.16% on first convening; allowing approval of all the resolutions submitted by the Board of Directors Lille, France;…
SEATTLE, May 24, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public…
Verrica has been advised that PAI (Pre-Approval Inspection) was conducted at Sterling and is not aware of any reported observations…
Form 20-F Filed on May 23, 2022 Following Receipt of Notice from Nasdaq Regarding Filing Deadline of its Annual ReportNEW…